Esophageal Cancer Clinical Trial

Removal of the Evolution® Esophageal Stent – Fully Covered

Summary

The CLARITY study is a clinical trial approved by US FDA to study the removal of the Evolution® Esophageal Stent-Fully Covered in malignant and benign indications.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Patient is diagnosed with benign or malignant stricture, fistula, perforation, or leak
Physician plans to remove the stent within the duration of study follow-up

Exclusion Criteria:

Patient is < 18 years of age
Patient is unable or unwilling to provide written informed consent or comply with follow-up schedule
Patient is pregnant, lactating, or planning on being pregnant within the next 6 months
Patient is simultaneously participating in another investigational drug or device study
Patient that is contraindicated to upper GI endoscopy and/or any procedure to be performed in conjunction with esophageal stent placement
Patient has a known hypersensitivity or contraindication to study products that, in the opinion of the investigator, cannot be adequately pre-medicated

Study is for people with:

Esophageal Cancer

Estimated Enrollment:

130

Study ID:

NCT01900691

Recruitment Status:

Completed

Sponsor:

Cook Group Incorporated

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There are 11 Locations for this study

See Locations Near You

Mayo Clinic
Phoenix Arizona, 85054, United States
Harbor-University of California Los Angeles Medical Center
Torrance California, 90502, United States
Emory University Hospital
Atlanta Georgia, 30322, United States
Loyola University Medical Center
Maywood Illinois, 60153, United States
University of Louisville, Division of Surgical Oncology
Louisville Kentucky, 40202, United States
University of Mississippi Medical Center
Jackson Mississippi, 39216, United States
Cleveland Clinic
Cleveland Ohio, 44195, United States
Thomas Jefferson University
Philadelphia Pennsylvania, 19107, United States
Methodist Dallas Medical Center
Dallas Texas, 75203, United States
University of Virginia Health System
Charlottesville Virginia, 22908, United States
Froedtert Hospital
Milwaukee Wisconsin, 53226, United States

How clear is this clinincal trial information?

Study is for people with:

Esophageal Cancer

Estimated Enrollment:

130

Study ID:

NCT01900691

Recruitment Status:

Completed

Sponsor:


Cook Group Incorporated

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider